UCL School of Life and Medical Sciences

• Links:
• UCL Institute for Global Health
• UCL Primary Care & Population Health

Professor Mark Pepys FRS (Centre for Amyloidosis & Acute Phase Proteins, Division of Medicine) has recently been awarded two grants by the MRC totalling £4.6 million to support his translational research and development programme.  The MRC’s new Developmental Clinical Studies Scheme was introduced last year to support development and initial clinical testing of new drugs (http://tinyurl.com/3yncev4).  One of the first three awards made under the scheme has gone to Professor Pepys, providing £3.84 million to fund the development of the compound he invented to inhibit C-reactive protein for the treatment of cardiovascular and inflammatory diseases (http://tinyurl.com/33p6ypp).  The other major interest of the Pepys team is amyloidosis, a rare and usually fatal illness.  The NHS National Amyloidosis Centre is part of the Centre for Amyloidosis and Acute Phase Proteins at the UCL Royal Free Campus (www.ucl.ac.uk/medicine/amyloidosis).  Professor Pepys has lately invented a new approach to treatment of amyloid, comprising a combination of a small molecule drug he had previously developed and a monoclonal antibody.  This invention was licensed to GlaxoSmithKline last year and is being actively developed for clinical studies (http://tinyurl.com/364f3vq).  The MRC are supporting UCL’s work on this treatment with a new Research Grant of £802,000 which continues the work of the MRC Programme Grant in this field that Professor Pepys has held continuously since 1979.  These awards confirm UCL’s position at the forefront of translational biomedical research.

• Links:
• Listen to Professor Watt on BBC’s Today programme
• Coverage in The Independent
• Research paper on BMJ.com
• Professor Richard Watt

The ‘At the Limits’ Medical Education series is now endorsed by, and produced in collaboration with, The Lancet medical journal. The ‘series represents a unique partnership between UCL and the University of Cape Town, it brings together the world's leading speakers in major disease areas, and enables them to share their knowledge with their senior peers in a leading edge academic environment. The events give attendees the opportunity to network with colleagues from medicine, academia, government and regulatory bodies.

• Links:
• UCL Arts & Humanities
• UCL Jill Dando Institute of Crime Science

• Links:
• Roots & Shoots
• UCL Union Volunteering Services Unit
• UCL Grant Museum of Zoology

• Links
• Dr Helen Birch
• UCL Institute of Orthopaedics and Musculoskeletal Science
• UCL Centre for Stem Cells and Regenerative Medicine
• Study in the Journal of Biological Chemistry

• Links:
• Professor Gabriel Aeppli
• Professor Ray Dolan
• The Royal Society

• Links:
• Professor Alimuddin Zumla
• UCL Division of Infection and Immunity
• The Lancet Series
• The Lancet TB Series articles
• The Challenge of TB symposium films
• UCL Global Health
• Download 'The Challenge of TB: UCL's contribution'

• Links:
• London Higher publication (pdf)
• UCL & London